$CUTR
CUTERA INC Stock $cutr

$cutr Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 10-K Financial Statement

#000162828024022628 Filed on May 10, 2024

Income Statement

Concept	2023 Q4	2023	2022 Q4
Revenue	$49.54M	$212.4M	$67.35M
YoY Change	-26.45%	-15.86%	2.63%
Cost Of Revenue	$43.30M	$152.0M	$28.60M
YoY Change	51.37%	34.99%	4.21%
Gross Profit	$6.241M	$60.41M	$38.75M
YoY Change	-83.89%	-56.8%	1.49%
Gross Profit Margin	12.6%	28.45%	57.53%
Selling, General & Admin	$45.99M	$182.0M	$38.88M
YoY Change	18.3%	19.08%	18.15%
% of Gross Profit	736.95%	301.31%	100.33%
Research & Development	$4.564M	$21.41M	$5.408M
YoY Change	-15.61%	-14.9%	-20.52%
% of Gross Profit	73.13%	35.44%	13.96%
Depreciation & Amortization	$3.350M	$8.575M	$1.018M
YoY Change	229.08%	227.17%	208.48%
% of Gross Profit	53.68%	14.19%	2.63%
Operating Expenses	$50.56M	$203.4M	$44.29M
YoY Change	14.16%	14.28%	10.13%
Operating Profit	-$44.32M	-$143.0M	-$5.536M
YoY Change	700.51%	274.51%	172.84%
Interest Expense	-$1.183M	-$3.073M	-$457.0K
YoY Change	158.86%	0.49%	-41.18%
% of Operating Profit
Other Income/Expense, Net	$1.038M	-$3.196M	-$1.031M
YoY Change	-200.68%	-36.47%	59.1%
Pretax Income	-$44.46M	-$149.3M	-$7.024M
YoY Change	532.99%	85.0%	103.36%
Income Tax	$769.0K	$1.534M	$764.0K
% Of Pretax Income
Net Earnings	-$45.23M	-$150.8M	-$7.788M
YoY Change	480.77%	83.18%	97.92%
Net Earnings / Revenue	-91.3%	-71.02%	-11.56%
Basic Earnings Per Share	-$2.87	-$8.19	-$0.40
Diluted Earnings Per Share	-$2.27	-$7.59	-$0.40
COMMON SHARES
Basic Shares Outstanding		19.89M shares	19.62M shares
Diluted Shares Outstanding		19.89M shares

Balance Sheet

Concept	2023 Q4	2023	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$143.6M	$143.6M	$317.3M
YoY Change	-54.74%	-54.74%	93.29%
Cash & Equivalents	$143.6M	$143.6M	$145.9M
Short-Term Investments	$0.00	$0.00	$171.4M
Other Short-Term Assets	$19.63M	$19.63M	$24.74M
YoY Change	-20.65%	-20.65%	70.07%
Inventory	$61.73M	$61.73M	$63.63M
Prepaid Expenses	$3.819M		$2.972M
Receivables	$43.37M	$43.37M	$45.56M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$268.3M	$268.3M	$451.2M
YoY Change	-40.53%	-40.53%	80.74%
LONG-TERM ASSETS
Property, Plant & Equipment	$47.33M	$47.33M	$53.20M
YoY Change	-11.03%	-11.03%	201.48%
Goodwill	$1.339M		$1.300M
YoY Change	3.0%		-2.91%
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$38.17M	$38.17M	$15.21M
YoY Change	150.92%	150.92%	49.57%
Total Long-Term Assets	$86.83M	$86.83M	$69.75M
YoY Change	24.5%	24.5%	127.7%
TOTAL ASSETS
Total Short-Term Assets	$268.3M	$268.3M	$451.2M
Total Long-Term Assets	$86.83M	$86.83M	$69.75M
Total Assets	$355.2M	$355.2M	$521.0M
YoY Change	-31.83%	-31.83%	85.87%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$19.83M	$19.83M	$33.74M
YoY Change	-41.22%	-41.22%	327.53%
Accrued Expenses	$54.37M	$54.37M	$60.26M
YoY Change	-9.78%	-9.78%	11.39%
Deferred Revenue	$10.42M		$11.84M
YoY Change	-11.98%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$825.0K	$825.0K	$485.0K
YoY Change	70.1%	70.1%	-12.45%
Total Short-Term Liabilities	$84.62M	$84.62M	$105.8M
YoY Change	-20.05%	-20.05%	43.22%
LONG-TERM LIABILITIES
Long-Term Debt	$418.7M	$418.7M	$416.5M
YoY Change	0.54%	0.54%	208.55%
Other Long-Term Liabilities	$11.68M	$11.68M	$13.87M
YoY Change	-15.8%	-15.8%	1717.96%
Total Long-Term Liabilities	$430.4M	$430.4M	$430.3M
YoY Change	0.01%	0.01%	56299.74%
TOTAL LIABILITIES
Total Short-Term Liabilities	$84.62M	$84.62M	$105.8M
Total Long-Term Liabilities	$430.4M	$430.4M	$430.3M
Total Liabilities	$515.0M	$515.0M	$536.2M
YoY Change	-3.95%	-3.95%	139.66%
SHAREHOLDERS EQUITY
Retained Earnings	-$303.3M		-$140.5M
YoY Change	115.88%		141.54%
Common Stock	$131.5M		$125.4M
YoY Change	4.86%		9.31%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	-$159.8M	-$159.8M	-$15.18M
YoY Change
Total Liabilities & Shareholders Equity	$355.2M	$355.2M	$521.0M
YoY Change	-31.83%	-31.83%	85.87%

Cashflow Statement

Concept	2023 Q4	2023	2022 Q4
OPERATING ACTIVITIES
Net Income	-$45.23M	-$150.8M	-$7.788M
YoY Change	480.77%	83.18%	97.92%
Depreciation, Depletion And Amortization	$3.350M	$8.575M	$1.018M
YoY Change	229.08%	227.17%	208.48%
Cash From Operating Activities	-$33.77M	-$137.6M	-$17.03M
YoY Change	98.35%	105.45%	-739.39%
INVESTING ACTIVITIES
Capital Expenditures	$2.599M	$33.24M	$8.591M
YoY Change	-69.75%	46.45%	-1457.19%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$170.4M	$33.80M
YoY Change	-100.0%	-199.39%
Cash From Investing Activities	-$2.599M	$137.2M	$25.21M
YoY Change	-110.31%	-170.65%	-4082.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net		$1.323M
YoY Change		-102.45%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-232.0K	-2.568M	91.86M
YoY Change	-100.25%	-101.06%	26297.7%
NET CHANGE
Cash From Operating Activities	-33.77M	-137.6M	-17.03M
Cash From Investing Activities	-2.599M	137.2M	25.21M
Cash From Financing Activities	-232.0K	-2.568M	91.86M
Net Change In Cash	-36.60M	-3.012M	100.0M
YoY Change	-136.59%	-83.49%	4107.06%
FREE CASH FLOW
Cash From Operating Activities	-$33.77M	-$137.6M	-$17.03M
Capital Expenditures	$2.599M	$33.24M	$8.591M
Free Cash Flow	-$36.37M	-$170.9M	-$25.62M
YoY Change	41.98%	90.52%	-877.25%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001162461
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-50644
CY2023	dei	Entity Registrant Name EntityRegistrantName	CUTERA, INC.
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	77-0492262
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	3240 Bayshore Blvd.
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Brisbane
CY2023	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	94005
CY2023	dei	City Area Code CityAreaCode	415
CY2023	dei	Local Phone Number LocalPhoneNumber	657-5500
CY2023	dei	Security12b Title Security12bTitle	Common Stock ($0.001 par value)
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2023	dei	Entity Small Business EntitySmallBusiness	false
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	40368000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	579000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	590000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10055000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	12831000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1339000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1339000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	11575000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	14620000	usd
CY2021	us-gaap	Interest Income Expense Nonoperating Net InterestIncomeExpenseNonoperatingNet	17000	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	231270000	usd
CY2021	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	98165000	usd
CY2021	us-gaap	Gross Profit GrossProfit	133105000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	76762000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21568000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	32945000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	2062000	usd
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17891000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18362000	shares
CY2021	us-gaap	Net Income Loss NetIncomeLoss	2062000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax	0	usd
CY2022	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	1355000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	21408000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	63313000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	45917000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	689000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	828000	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	57000	usd
CY2022	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	908000	usd
CY2023	us-gaap	Amortization Of Financing Costs And Discounts AmortizationOfFinancingCostsAndDiscounts	2236000	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	5658000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset Statement Of Financial Position Extensible List FinanceLeaseRightOfUseAssetStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization
CY2023Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Finance Lease Liability Current Statement Of Financial Position Extensible List FinanceLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent Statement Of Financial Position Extensible List FinanceLeaseLiabilityNoncurrentStatementOfFinancialPositionExtensibleList	http://fasb.org/us-gaap/2023#OtherLiabilitiesNoncurrent
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Public Float EntityPublicFloat	301000000	usd
CY2024Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	20072096	shares
CY2023Q4	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	37	country
CY2023	dei	Auditor Name AuditorName	BDO USA, P.C.
CY2023	dei	Auditor Location AuditorLocation	San Francisco, California
CY2023	dei	Auditor Firm AuditorFirmId	243
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	143612000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	145924000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2022Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	171390000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	9878000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	2497000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	43121000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	45562000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	62600000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	63628000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19852000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	24036000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	0	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	700000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	269185000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	451240000	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	16283000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	0	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	37275000	usd
CY2023Q4	us-gaap	Assets Assets	346291000	usd
CY2022Q4	us-gaap	Assets Assets	520988000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	19829000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	33736000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	55055000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	57452000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2441000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2810000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	10422000	usd
CY2022Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	11841000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	87747000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	105839000	usd
CY2023Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1494000	usd
CY2022Q4	us-gaap	Deferred Revenue Noncurrent DeferredRevenueNoncurrent	1657000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8887000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	11352000	usd
CY2023Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	10430000	usd
CY2022Q4	us-gaap	Debt Instrument Unamortized Discount Premium And Debt Issuance Costs Net DebtInstrumentUnamortizedDiscountPremiumAndDebtIssuanceCostsNet	12666000	usd
CY2023Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	418695000	usd
CY2022Q4	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	416459000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1298000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	862000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	518121000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	536169000	usd
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19960622	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19960622	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19668603	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19668603	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	20000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	20000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	131496000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	125406000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-94000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-303346000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-140513000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-171830000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-15181000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	346291000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	520988000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	212369000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	252399000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	170875000	usd
CY2022	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	112570000	usd
CY2023	us-gaap	Gross Profit GrossProfit	41494000	usd
CY2022	us-gaap	Gross Profit GrossProfit	139829000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	113003000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	106947000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	25155000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	-156230000	usd
CY2023	us-gaap	Interest Expense Debt InterestExpenseDebt	11780000	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	2514000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-161299000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1534000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1638000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-162833000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-82340000	usd
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.19
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.39
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-8.19
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.39
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19885000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18747000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19885000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18747000	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-162833000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-82340000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax	94000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Available For Sale Securities Adjustment Before Reclassification Adjustments And Tax OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentBeforeReclassificationAdjustmentsAndTax	-94000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	94000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-94000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	0	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-162739000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-82434000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	2062000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	56880000	usd
CY2021	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1184000	usd
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	1581000	usd
CY2021	cutr	Purchase Of Capped Call PurchaseOfCappedCall	16134000	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-2176000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	13172000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	2062000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	56569000	usd
CY2022	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	1873000	usd
CY2022	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	850000	usd
CY2022	us-gaap	Payments Of Stock Issuance Costs PaymentsOfStockIssuanceCosts	452000	usd
CY2022	cutr	Purchase Of Capped Call PurchaseOfCappedCall	57132000	usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-5256000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14400000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	55949000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-82340000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-94000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	-15181000	usd
CY2023	us-gaap	Stock Issued During Period Value Employee Stock Purchase Plan StockIssuedDuringPeriodValueEmployeeStockPurchasePlan	711000	usd
CY2023	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	612000	usd
CY2023	us-gaap	Stock Issued During Period Value Restricted Stock Award Net Of Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures	-3297000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	8064000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-162833000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	94000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	-171830000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-162833000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-82340000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	2062000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	8064000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	14400000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	13172000	usd
CY2023	cutr	Depreciation And Amortization Excluding Contract Acquisition Costs DepreciationAndAmortizationExcludingContractAcquisitionCosts	8575000	usd
CY2022	cutr	Depreciation And Amortization Excluding Contract Acquisition Costs DepreciationAndAmortizationExcludingContractAcquisitionCosts	2621000	usd
CY2021	cutr	Depreciation And Amortization Excluding Contract Acquisition Costs DepreciationAndAmortizationExcludingContractAcquisitionCosts	1344000	usd
CY2023	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	8847000	usd
CY2022	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	3200000	usd
CY2021	us-gaap	Amortization Of Acquisition Costs AmortizationOfAcquisitionCosts	1857000	usd
CY2023	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	2236000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	1355000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	710000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	0	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	-558000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Unrealized ForeignCurrencyTransactionGainLossUnrealized	0	usd
CY2023	us-gaap	Hosting Arrangement Service Contract Implementation Cost Impairment HostingArrangementServiceContractImplementationCostImpairment	0	usd
CY2022	us-gaap	Hosting Arrangement Service Contract Implementation Cost Impairment HostingArrangementServiceContractImplementationCostImpairment	0	usd
CY2021	us-gaap	Hosting Arrangement Service Contract Implementation Cost Impairment HostingArrangementServiceContractImplementationCostImpairment	182000	usd
CY2023	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-11000	usd
CY2022	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-188000	usd
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	135000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	7381000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1787000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	87000	usd
CY2023	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	-1048000	usd
CY2022	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
CY2021	us-gaap	Other Noncash Income Expense OtherNoncashIncomeExpense	0	usd
CY2023	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-168000	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4940000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	15900000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	9574000	usd
CY2023	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-15574000	usd
CY2022	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	36305000	usd
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	10936000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-4137000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	10049000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	5765000	usd
CY2023	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	6243000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	8091000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	-14866000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	21608000	usd
CY2022	cutr	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	56000	usd
CY2021	cutr	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	141000	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1582000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	2673000	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-412000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-137870000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-66995000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	1235000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	33010000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	22698000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1015000	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	71000	usd
CY2023	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	193903000	usd
CY2022	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	158000000	usd
CY2021	us-gaap	Proceeds From Maturities Prepayments And Calls Of Available For Sale Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities	0	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	23467000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	329484000	usd
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	137426000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-194182000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-944000	usd
CY2023	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	1323000	usd
CY2022	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2723000	usd
CY2021	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions	2765000	usd
CY2023	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	0	usd
CY2022	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	56680000	usd
CY2021	us-gaap	Payments For Derivative Instrument Financing Activities PaymentsForDerivativeInstrumentFinancingActivities	16134000	usd
CY2023	us-gaap	Payments Of Derivative Issuance Costs PaymentsOfDerivativeIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Derivative Issuance Costs PaymentsOfDerivativeIssuanceCosts	352000	usd
CY2021	us-gaap	Payments Of Derivative Issuance Costs PaymentsOfDerivativeIssuanceCosts	0	usd
CY2023	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	usd
CY2022	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	360000000	usd
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	138250000	usd
CY2023	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	0	usd
CY2022	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	11202000	usd
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	4717000	usd
CY2023	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2022	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	45776000	usd
CY2021	us-gaap	Payments Of Debt Extinguishment Costs PaymentsOfDebtExtinguishmentCosts	0	usd
CY2023	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	3297000	usd
CY2022	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	5256000	usd
CY2021	us-gaap	Payments Related To Tax Withholding For Share Based Compensation PaymentsRelatedToTaxWithholdingForShareBasedCompensation	2176000	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	594000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	520000	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	462000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-2568000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	242937000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	117526000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3012000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-18240000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	117817000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	146624000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	164864000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	47047000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	143612000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	146624000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	164864000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	11696000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	5486000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	1663000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	1418000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	2004000	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	891000	usd
CY2023	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2022	us-gaap	Stock Issued1 StockIssued1	55947000	usd
CY2021	us-gaap	Stock Issued1 StockIssued1	0	usd
CY2023	us-gaap	Right Of Use Asset Obtained In Exchange For Finance Lease Liability RightOfUseAssetObtainedInExchangeForFinanceLeaseLiability	1853000	usd
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	123000	usd
CY2023	us-gaap	Notes Reduction NotesReduction	0	usd
CY2022	us-gaap	Notes Reduction NotesReduction	0	usd
CY2021	us-gaap	Notes Reduction NotesReduction	7185000	usd
CY2023	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	usd
CY2022	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	635000	usd
CY2021	us-gaap	Debt Issuance Costs Incurred During Noncash Or Partial Noncash Transaction DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction	0	usd
CY2023	cutr	Accrued Capped Call Costs AccruedCappedCallCosts	0	usd
CY2022	cutr	Accrued Capped Call Costs AccruedCappedCallCosts	100000	usd
CY2021	cutr	Accrued Capped Call Costs AccruedCappedCallCosts	0	usd
CY2023	us-gaap	Property Plant And Equipment Transfers And Changes PropertyPlantAndEquipmentTransfersAndChanges	0	usd
CY2022	us-gaap	Property Plant And Equipment Transfers And Changes PropertyPlantAndEquipmentTransfersAndChanges	12180000	usd
CY2021	us-gaap	Property Plant And Equipment Transfers And Changes PropertyPlantAndEquipmentTransfersAndChanges	0	usd
CY2023	cutr	Inventory Transfers And Changes InventoryTransfersAndChanges	27757000	usd
CY2022	cutr	Inventory Transfers And Changes InventoryTransfersAndChanges	0	usd
CY2021	cutr	Inventory Transfers And Changes InventoryTransfersAndChanges	0	usd
CY2023	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	5090000	usd
CY2022	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	4131000	usd
CY2021	us-gaap	Payments To Acquire Productive Assets PaymentsToAcquireProductiveAssets	0	usd
CY2023Q4	us-gaap	Number Of Countries In Which Entity Operates NumberOfCountriesInWhichEntityOperates	37	country
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-162800000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-82300000	usd
CY2023	us-gaap	Prior Period Reclassification Adjustment Description PriorPeriodReclassificationAdjustmentDescription	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reclassification</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications of prior period amounts have been made in the Company's consolidated statement of cash flows to conform to the current period presentation. These reclassifications had no effect on the reported net changes in operating, investing and financing activities, as well as net change in cash, cash equivalents, and restricted cash.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Certain reclassifications of prior period amounts have been made in the Company's consolidated statement of operations to conform to the current period presentation. These reclassifications had no effect on the reported net income (loss).</span></div>
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of consolidated financial statements in conformity with GAAP requires the Company’s management to make estimates and assumptions that affect the amounts reported of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the accompanying notes, and the reported amounts of revenue and expenses during the reported periods. Actual results could differ materially from those estimates.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On an ongoing basis, management evaluates its estimates, including those related to warranty obligations, sales commissions, allowance for credit losses, sales allowances, fair value of investments, valuation of inventories, fair value of goodwill, useful lives of property and equipment, impairment testing for long-lived assets, implicit and incremental borrowing rates related to the Company’s leases, variables used in calculating the fair value of the Company's equity awards, expected achievement of performance-based vesting criteria and management performance bonuses, assumptions used in operating and sales-type lease classifications, the standalone selling price of the Company's products and services, the period of benefit used to capitalize and amortize contract acquisition costs, variable considerations, contingent liabilities, recoverability of deferred tax assets, residual value of leased equipment, lease term and effective income tax rates. Management bases estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities.</span></div>
CY2023	cutr	Contract With Customer Liability Training Provided With Sale Of System Period ContractWithCustomerLiabilityTrainingProvidedWithSaleOfSystemPeriod	P90D
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Concentration of Credit Risk and Other Risks and Uncertainties</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company operates in markets that are highly competitive and rapidly changing. Significant technological changes, shifting customer needs, the emergence of competitive products or services with new capabilities and other factors could negatively impact the Company’s operating results.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company is also subject to risks related to changes in the value of the Company’s significant balance of financial instruments. Financial instruments that potentially subject the Company to concentrations of risk consist principally of cash, cash equivalents, marketable investments, and accounts receivable. The Company’s cash and cash equivalents are primarily invested in deposits and money market accounts with two major financial institutions in the U.S. In addition, the Company has operating cash balances in banks in each of the international locations in which it operates. Deposits in these banks may exceed the federally insured limits or any other insurance provided on such deposits, if any. The Company has accounts with Silicon Valley Bank (“SVB”). On March 10, 2023, California regulators shut down SVB and the FDIC was appointed as SVB’s receiver. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 26, 2023, the FDIC announced that it had entered into a purchase and assumption agreement with First-Citizens Bank & Trust Company under which all deposits of the former Silicon Valley Bank were assumed by First-Citizens Bank & Trust Company. To date, the Company has not experienced any losses on its deposits of cash, cash equivalents, and marketable investments and continues to have access to these funds. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Accounts receivable are recorded net of an allowance for credit losses and are typically unsecured and are derived from revenue earned from worldwide customers. The Company controls credit risk through credit approvals, credit limits, and monitoring procedures. The Company performs credit evaluations of its customers and maintains an allowance for potential credit losses. As of December 31, 2023 and 2022, no customer represented more than 10% of the Company’s net accounts receivable. During the years ended December 31, 2023, 2022, and 2021, domestic revenue accounted for 42%, 43%, and 42%, respectively, of total revenue, while international revenue accounted for 58%, 57% and 58%, respectively, of total revenue. No single customer represented more than 10% of total revenue for any of the years ended December 31, 2023, 2022, and 2021.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Distribution of Third-Party Products </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generated revenue from the distribution of skincare products, which were manufactured by ZO Skin Health, Inc. (“ZO”), and sold in the Japanese market. In the years ended December 31, 2023, 2022, and 2021 revenue from the distribution of skincare products was $34.0 million, $42.5 million, and $49.7 million, respectively, representing 16%, 17%, and 21% of the Company’s consolidated revenue, respectively. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On February 28, 2024, the Company and its Japanese subsidiary, Cutera KK, entered into a termination agreement with ZO, which terminated all agreements related to the distribution by the Company of ZO’s products in Japan, as further disclosed in </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Note 16. Subsequent Events </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">to the Company's consolidated financial statements. </span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company generates revenue from the distribution of the Secret systems, which are manufactured by Ilooda Co. Ltd. (“ilooda”). The Company is the exclusive distributor for all systems sold in North America and the United Kingdom; the exclusive distributor for certain systems in France and Spain; and the non-exclusive distributor for systems sold in Austria and Germany. In the years ended December 31, 2023, 2022, and 2021, revenue from the distribution of Secret products was $9.2 million, $14.8 million, and $12.3 million, respectively, representing 4%, 6%, and 5% of the Company’s consolidated revenue, respectively. The Company‘s ilooda distribution agreement expires on June 30, 2026.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">In March 2023, Serendia, LLC (“Serendia”) filed patent infringement complaints against the Company regarding the Secret RF and Secret Pro systems distributed by the Company on behalf of ilooda. The complaints alleged infringement of six Serendia patents. Serendia and ilooda have moved to terminate the ITC Investigation as to ilooda and Cutera on the basis of settlement with Serendia. The ITC investigation as to ilooda and the Company was terminated as of April 10, 2024 and the Delaware litigation was dismissed as of April 3, 2024.</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Supplier concentration</span></div><div style="margin-top:10pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company relies on third parties for the supply of components of its products, as well as third-party logistics providers. In instances where these parties fail to perform their obligations, the Company may be unable to find alternative suppliers or satisfactorily deliver its products to its customers. The Company largest supplier provided approximately 7%, 10% and 14% of the Company's total purchases in the years ended December 31, 2023, 2022, and 2021, respectively.</span></div>
CY2023Q1	us-gaap	Loss Contingency Patents Allegedly Infringed Number LossContingencyPatentsAllegedlyInfringedNumber	6	patent
CY2023	cutr	Demonstration Units Amortization Period DemonstrationUnitsAmortizationPeriod	P2Y
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5800000	usd
CY2022Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	5700000	usd
CY2023	us-gaap	Depreciation Depreciation	8100000	usd
CY2022	us-gaap	Depreciation Depreciation	2200000	usd
CY2021	us-gaap	Depreciation Depreciation	1300000	usd
CY2023	us-gaap	Hosting Arrangement Service Contract Implementation Cost Expense Amortization HostingArrangementServiceContractImplementationCostExpenseAmortization	400000	usd
CY2022	us-gaap	Hosting Arrangement Service Contract Implementation Cost Expense Amortization HostingArrangementServiceContractImplementationCostExpenseAmortization	400000	usd
CY2021	us-gaap	Hosting Arrangement Service Contract Implementation Cost Expense Amortization HostingArrangementServiceContractImplementationCostExpenseAmortization	0	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023	cutr	Standard Product Warranty Term Direct Sales StandardProductWarrantyTermDirectSales	P12M
CY2023	cutr	Standard Product Warranty Term Distributor Sales StandardProductWarrantyTermDistributorSales	P14M
CY2023	us-gaap	Advertising Expense AdvertisingExpense	4500000	usd
CY2022	us-gaap	Advertising Expense AdvertisingExpense	4900000	usd
CY2021	us-gaap	Advertising Expense AdvertisingExpense	2100000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	300000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-3600000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-1800000	usd
CY2023	us-gaap	Number Of Reporting Units NumberOfReportingUnits	1	segment
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1	segment
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	143600000	usd
CY2023Q4	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	0	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	145924000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	700000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	146624000	usd
CY2022Q4	cutr	Cash Cash Equivalents And Available For Sale Debt Securities Amortized Cost CashCashEquivalentsAndAvailableForSaleDebtSecuritiesAmortizedCost	171484000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	8000	usd
CY2022Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	102000	usd
CY2022Q4	cutr	Cash Cash Equivalents And Available For Sale Debt Securities CashCashEquivalentsAndAvailableForSaleDebtSecurities	318014000	usd
CY2022	us-gaap	Available For Sale Debt Securities Gross Unrealized Loss AvailableForSaleDebtSecuritiesGrossUnrealizedLoss	100000	usd
CY2022Q4	us-gaap	Letters Of Credit Outstanding Amount LettersOfCreditOutstandingAmount	700000	usd
CY2023Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	13000000	usd
CY2022Q4	us-gaap	Inventory Valuation Reserves InventoryValuationReserves	3600000	usd
CY2023Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	36970000	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	36323000	usd
CY2023Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	889000	usd
CY2022Q4	us-gaap	Inventory Work In Process Net Of Reserves InventoryWorkInProcessNetOfReserves	2117000	usd
CY2023Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	24741000	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	25188000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	62600000	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	63628000	usd
CY2023Q4	cutr	Inventory Noncurrent Valuation Reserves InventoryNoncurrentValuationReserves	12800000	usd
CY2023Q4	cutr	Inventory Raw Materials Noncurrent InventoryRawMaterialsNoncurrent	8672000	usd
CY2022Q4	cutr	Inventory Raw Materials Noncurrent InventoryRawMaterialsNoncurrent	0	usd
CY2023Q4	cutr	Inventory Work In Process Noncurrent InventoryWorkInProcessNoncurrent	2049000	usd
CY2022Q4	cutr	Inventory Work In Process Noncurrent InventoryWorkInProcessNoncurrent	0	usd
CY2023Q4	cutr	Inventory Finished Goods Noncurrent InventoryFinishedGoodsNoncurrent	5562000	usd
CY2022Q4	cutr	Inventory Finished Goods Noncurrent InventoryFinishedGoodsNoncurrent	0	usd
CY2023Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	16283000	usd
CY2022Q4	us-gaap	Inventory Noncurrent InventoryNoncurrent	0	usd
CY2023Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	9501000	usd
CY2022Q4	us-gaap	Deposits Assets Current DepositsAssetsCurrent	13917000	usd
CY2023Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	6307000	usd
CY2022Q4	us-gaap	Income Taxes Receivable IncomeTaxesReceivable	7147000	usd
CY2023Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	3819000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	2972000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	225000	usd
CY2022Q4	us-gaap	Other Assets Current OtherAssetsCurrent	0	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	19852000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	24036000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	47602000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Before Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetBeforeAccumulatedDepreciationAndAmortization	45615000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	10327000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAccumulatedDepreciationAndAmortization	5247000	usd
CY2023Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	37275000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	40368000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	1300000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	1300000	usd
CY2023	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	13949000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	18951000	usd
CY2023Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	6325000	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	9066000	usd
CY2023Q4	cutr	Accrued Inventory In Transit Current AccruedInventoryInTransitCurrent	5461000	usd
CY2022Q4	cutr	Accrued Inventory In Transit Current AccruedInventoryInTransitCurrent	7028000	usd
CY2023Q4	cutr	Sales And Marketing Accruals Current SalesAndMarketingAccrualsCurrent	4929000	usd
CY2022Q4	cutr	Sales And Marketing Accruals Current SalesAndMarketingAccrualsCurrent	5347000	usd
CY2023Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	2593000	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	3254000	usd
CY2023Q4	cutr	Litigation Settlement Payable Current LitigationSettlementPayableCurrent	8908000	usd
CY2022Q4	cutr	Litigation Settlement Payable Current LitigationSettlementPayableCurrent	0	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	12890000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	13806000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	55055000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	57452000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3254000	usd
CY2021Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3947000	usd
CY2023	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	4987000	usd
CY2022	us-gaap	Standard Product Warranty Accrual Warranties Issued StandardProductWarrantyAccrualWarrantiesIssued	3710000	usd
CY2023	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	5648000	usd
CY2022	us-gaap	Standard Product Warranty Accrual Payments StandardProductWarrantyAccrualPayments	4403000	usd
CY2023Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	2593000	usd
CY2022Q4	us-gaap	Standard Product Warranty Accrual StandardProductWarrantyAccrual	3254000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Percentage RevenueRemainingPerformanceObligationPercentage	0.87
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	11900000	usd
CY2023Q4	us-gaap	Revenue Remaining Performance Obligation Expected Timing Of Satisfaction Period1 RevenueRemainingPerformanceObligationExpectedTimingOfSatisfactionPeriod1	P12M
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	13498000	usd
CY2021Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	10825000	usd
CY2023	cutr	Contract With Customer Liability Increase Advance Payments Received ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived	21040000	usd
CY2022	cutr	Contract With Customer Liability Increase Advance Payments Received ContractWithCustomerLiabilityIncreaseAdvancePaymentsReceived	21984000	usd
CY2023	cutr	Contract With Customer Liability Decrease From Revenue Deferred ContractWithCustomerLiabilityDecreaseFromRevenueDeferred	11732000	usd
CY2022	cutr	Contract With Customer Liability Decrease From Revenue Deferred ContractWithCustomerLiabilityDecreaseFromRevenueDeferred	9928000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	10890000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	9383000	usd
CY2023Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	11916000	usd
CY2022Q4	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	13498000	usd
CY2023	cutr	Costs For Extended Service Contracts CostsForExtendedServiceContracts	7300000	usd
CY2022	cutr	Costs For Extended Service Contracts CostsForExtendedServiceContracts	6300000	usd
CY2021	cutr	Costs For Extended Service Contracts CostsForExtendedServiceContracts	8300000	usd
CY2021Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	31400000	usd
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2023Q4	cutr	Capital Stock Shares Authorized CapitalStockSharesAuthorized	55000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	50000000	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	19960622	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	19960622	shares
CY2023Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2023Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2023Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2023Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2019	cutr	Share Based Compensation Arrangement By Share Based Payment Award Officers Percentage To Be Held For A Minimum Of One Year ShareBasedCompensationArrangementByShareBasedPaymentAwardOfficersPercentageToBeHeldForAMinimumOfOneYear	0.50
CY2021Q3	cutr	Share Based Compensation Arrangement By Share Based Payment Award Number Of Vesting Tranches ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfVestingTranches	4	tranche
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1085170	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	217007	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	22.35
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y9M
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	1470000	usd
CY2021	cutr	Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Additional Share Reserved ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalShareReserved	450000	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	172139	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	172139	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	30.71
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	71798	shares
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	22.02
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	30173	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	30173	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	37.14
CY2021	cutr	Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross	744949	shares
CY2021	cutr	Share Based Compensation Arrangement By Based Payment Restricted Share Available For Grant Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod	299092	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	947347	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	287175	shares
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	25.89
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P4Y11M1D
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	4460000	usd
CY2022	cutr	Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Additional Share Reserved ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalShareReserved	600000	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	296238	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	296238	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	40.95
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	39960	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	21.28
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	29518	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	29518	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	34.91
CY2022	cutr	Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross	374274	shares
CY2022	cutr	Share Based Compensation Arrangement By Based Payment Restricted Share Available For Grant Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod	164572	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	1070925	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	513935	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	34.41
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P6Y7M17D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	5990000	usd
CY2023	cutr	Share Based Compensation Arrangement By Share Based Payment Shares Available For Grant Additional Share Reserved ShareBasedCompensationArrangementByShareBasedPaymentSharesAvailableForGrantAdditionalShareReserved	3800000	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	1099075	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	13.10
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	42234	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	14.50
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	288536	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	288536	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	29.21
CY2023	cutr	Share Based Compensation Arrangement By Share Based Payment Award Shares Available For Grant In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesAvailableForGrantInPeriodGross	2144988	shares
CY2023	cutr	Share Based Compensation Arrangement By Based Payment Restricted Share Available For Grant Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByBasedPaymentRestrictedShareAvailableForGrantAwardOptionsForfeituresAndExpirationsInPeriod	540064	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Available For Grant ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant	3554537	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	1282240	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	17.97
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y2M15D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	190997	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	36.39
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P3Y4M9D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	0	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	1180944	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	18.37
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P8Y1M9D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	0	usd
CY2023Q4	us-gaap	Share Price SharePrice	3.53
CY2022Q4	us-gaap	Share Price SharePrice	44.22
CY2021Q4	us-gaap	Share Price SharePrice	41.32
CY2020Q4	us-gaap	Share Price SharePrice	24.11
CY2023	cutr	Share Based Payment Arrangement Shares Granted Tax Withholding Ratio ShareBasedPaymentArrangementSharesGrantedTaxWithholdingRatio	1.65
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	300000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1100000	usd
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	1300000	usd
CY2023	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit	3.67
CY2023	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit	63.62
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	1282240	shares
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P8Y2M15D
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	190997	shares
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8064000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14400000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13172000	usd
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	8064000	usd
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	14400000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	13172000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-165784000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-84189000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	-356000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	4485000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	3487000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	3741000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-161299000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-80702000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3385000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	52000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	0	usd
CY2023	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	46000	usd
CY2022	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	126000	usd
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	-87000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1471000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1275000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1512000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1517000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1453000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	1425000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	6000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	2000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	2000	usd
CY2023	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1000	usd
CY2022	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1000	usd
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	1000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	10000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	182000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-105000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	17000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	185000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-102000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1534000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1638000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1323000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	47406000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	21443000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2014000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2594000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	12552000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther	4592000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	18614000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	14908000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	759000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Warranty Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsWarrantyReserves	778000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1241000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Property Plant And Equipment DeferredTaxAssetsPropertyPlantAndEquipment	1857000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	13391000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Other DeferredTaxAssetsTaxDeferredExpenseOther	7578000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	2965000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	1541000	usd
CY2023Q4	cutr	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	2842000	usd
CY2022Q4	cutr	Deferred Tax Assets Operating Lease Liability DeferredTaxAssetsOperatingLeaseLiability	3384000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	101784000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	58675000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	97280000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	53118000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	4504000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet	5557000	usd
CY2023Q4	cutr	Deferred Tax Liabilities Deferred Contract Acquisition Costs DeferredTaxLiabilitiesDeferredContractAcquisitionCosts	1287000	usd
CY2022Q4	cutr	Deferred Tax Liabilities Deferred Contract Acquisition Costs DeferredTaxLiabilitiesDeferredContractAcquisitionCosts	1763000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	159000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets Goodwill DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsGoodwill	138000	usd
CY2023Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	2479000	usd
CY2022Q4	us-gaap	Deferred Tax Liabilities Leasing Arrangements DeferredTaxLiabilitiesLeasingArrangements	3066000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	579000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Liabilities Net DeferredTaxAssetsLiabilitiesNet	590000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.2100
CY2023	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0002
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0016
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.0255
CY2023	cutr	Effective Income Tax Rate Reconciliation Meals And Entertainment Percent EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent	-0.0025
CY2022	cutr	Effective Income Tax Rate Reconciliation Meals And Entertainment Percent EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent	-0.0047
CY2021	cutr	Effective Income Tax Rate Reconciliation Meals And Entertainment Percent EffectiveIncomeTaxRateReconciliationMealsAndEntertainmentPercent	0.0928
CY2023	cutr	Effective Income Tax Rate Reconciliation Permanent Differences Percent EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent	0.0024
CY2022	cutr	Effective Income Tax Rate Reconciliation Permanent Differences Percent EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent	-0.0007
CY2021	cutr	Effective Income Tax Rate Reconciliation Permanent Differences Percent EffectiveIncomeTaxRateReconciliationPermanentDifferencesPercent	0.0111
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.0043
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	0.0089
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Compensation Cost EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost	-0.1308
CY2023	cutr	Effective Income Tax Rate Reconciliation Extinguishment Of Loan Percent EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent	-0.0007
CY2022	cutr	Effective Income Tax Rate Reconciliation Extinguishment Of Loan Percent EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent	0
CY2021	cutr	Effective Income Tax Rate Reconciliation Extinguishment Of Loan Percent EffectiveIncomeTaxRateReconciliationExtinguishmentOfLoanPercent	-0.4459
CY2023	cutr	Effective Income Tax Reconciliation Debt Extinguishment Costs Percent EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent	0
CY2022	cutr	Effective Income Tax Reconciliation Debt Extinguishment Costs Percent EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent	-0.0848
CY2021	cutr	Effective Income Tax Reconciliation Debt Extinguishment Costs Percent EffectiveIncomeTaxReconciliationDebtExtinguishmentCostsPercent	0
CY2023	cutr	Effective Income Tax Rate Reconciliation Excess Compensation Percent EffectiveIncomeTaxRateReconciliationExcessCompensationPercent	-0.0019
CY2022	cutr	Effective Income Tax Rate Reconciliation Excess Compensation Percent EffectiveIncomeTaxRateReconciliationExcessCompensationPercent	-0.0134
CY2021	cutr	Effective Income Tax Rate Reconciliation Excess Compensation Percent EffectiveIncomeTaxRateReconciliationExcessCompensationPercent	0.0788
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0031
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	-0.0076
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.1703
CY2023	cutr	Effective Income Tax Rate Reconciliation Research And Development Percent EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent	0.0071
CY2022	cutr	Effective Income Tax Rate Reconciliation Research And Development Percent EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent	0.0078
CY2021	cutr	Effective Income Tax Rate Reconciliation Research And Development Percent EffectiveIncomeTaxRateReconciliationResearchAndDevelopmentPercent	-0.1795
CY2023	cutr	Effective Income Tax Rate Reconciliation Valuation Allowance Percent EffectiveIncomeTaxRateReconciliationValuationAllowancePercent	-0.2152
CY2022	cutr	Effective Income Tax Rate Reconciliation Valuation Allowance Percent EffectiveIncomeTaxRateReconciliationValuationAllowancePercent	-0.1141
CY2021	cutr	Effective Income Tax Rate Reconciliation Valuation Allowance Percent EffectiveIncomeTaxRateReconciliationValuationAllowancePercent	0.7282
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	0
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Prior Year Income Taxes EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes	-0.0008
CY2023	cutr	Effective Income Tax Rate Reconciliation Deferred Trueup Percent EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent	-0.0033
CY2022	cutr	Effective Income Tax Rate Reconciliation Deferred Trueup Percent EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent	-0.0202
CY2021	cutr	Effective Income Tax Rate Reconciliation Deferred Trueup Percent EffectiveIncomeTaxRateReconciliationDeferredTrueupPercent	-0.1176
CY2023	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0117
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	-0.0204
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.3911
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	97300000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	44200000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	12600000	usd
CY2023Q4	cutr	Operating Loss Carryforwards Without Expiration OperatingLossCarryforwardsWithoutExpiration	154200000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3725000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2746000	usd
CY2020Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1864000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions	258000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	36000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	37000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1013000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	1015000	usd
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	919000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	4996000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	3725000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	2746000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-162833000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-82340000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	2062000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	19885000	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	18747000	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	17891000	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	19885000	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18747000	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	18362000	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-8.19
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-4.39
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.12
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-8.19
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-4.39
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.11
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	21668000	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	20935000	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8652000	shares
CY2023Q4	cutr	Defined Contribution Plan Maximum Percentage Of Employee Voluntary Contribution DefinedContributionPlanMaximumPercentageOfEmployeeVoluntaryContribution	1
CY2023	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	500000	usd
CY2022	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	500000	usd
CY2021	us-gaap	Defined Contribution Plan Employer Discretionary Contribution Amount DefinedContributionPlanEmployerDiscretionaryContributionAmount	300000	usd
CY2023Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023Q4	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	1	segment
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	212369000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	252399000	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	231270000	usd
CY2023	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	212369000	usd
CY2022	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	252399000	usd
CY2021	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	231270000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10055000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	12831000	usd
CY2023Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	2516000	usd
CY2022Q4	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	1606000	usd
CY2023Q4	cutr	Lease Right Of Use Asset LeaseRightOfUseAsset	12571000	usd
CY2022Q4	cutr	Lease Right Of Use Asset LeaseRightOfUseAsset	14437000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2441000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	2810000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	8887000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	11352000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	11328000	usd
CY2022Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	14162000	usd
CY2023Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	825000	usd
CY2022Q4	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	485000	usd
CY2023Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	1064000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	825000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	1889000	usd
CY2022Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	1310000	usd
CY2023	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	790000	usd
CY2022	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	643000	usd
CY2021	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	484000	usd
CY2023	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	116000	usd
CY2022	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	76000	usd
CY2021	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	59000	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	3598000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	3560000	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	3542000	usd
CY2023	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	87000	usd
CY2022	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	78000	usd
CY2021	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	56000	usd
CY2023	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	594000	usd
CY2022	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	520000	usd
CY2021	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	462000	usd
CY2023	us-gaap	Operating Lease Payments OperatingLeasePayments	3297000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	2526000	usd
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	3092000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	2932000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2935000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	3030000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	3133000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Five LesseeOperatingLeaseLiabilityPaymentsDueYearFive	325000	usd
CY2023Q4	cutr	Lessee Operating Lease Liability To Be Paid After Year Five LesseeOperatingLeaseLiabilityToBePaidAfterYearFive	147000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	12502000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	1174000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	11328000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Next Twelve Months FinanceLeaseLiabilityPaymentsDueNextTwelveMonths	954000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Two FinanceLeaseLiabilityPaymentsDueYearTwo	704000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Three FinanceLeaseLiabilityPaymentsDueYearThree	424000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due Year Four FinanceLeaseLiabilityPaymentsDueYearFour	16000	usd
CY2023Q4	us-gaap	Finance Lease Liability Payments Due FinanceLeaseLiabilityPaymentsDue	2098000	usd
CY2023Q4	us-gaap	Finance Lease Liability Undiscounted Excess Amount FinanceLeaseLiabilityUndiscountedExcessAmount	209000	usd
CY2023Q4	us-gaap	Finance Lease Liability FinanceLeaseLiability	1889000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P4Y2M12D
CY2023Q4	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P2Y4M24D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.048
CY2023Q4	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.090
CY2023Q4	us-gaap	Lessor Operating Lease Term Of Contract LessorOperatingLeaseTermOfContract	P3Y
CY2023	cutr	Lessor Duration Of Autorenewal Features LessorDurationOfAutorenewalFeatures	P1Y
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Next Twelve Months LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths	7220000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received Two Years LessorOperatingLeasePaymentsToBeReceivedTwoYears	3185000	usd
CY2023Q4	us-gaap	Lessor Operating Lease Payments To Be Received LessorOperatingLeasePaymentsToBeReceived	10405000	usd
CY2023Q4	us-gaap	Purchase Obligation PurchaseObligation	10700000	usd
CY2023Q4	us-gaap	Litigation Reserve LitigationReserve	3300000	usd
CY2022Q4	us-gaap	Litigation Reserve LitigationReserve	500000	usd
CY2023Q1	us-gaap	Loss Contingency Patents Allegedly Infringed Number LossContingencyPatentsAllegedlyInfringedNumber	6	patent
CY2023Q1	us-gaap	Loss Contingency Patents Allegedly Infringed Number LossContingencyPatentsAllegedlyInfringedNumber	6	patent
CY2023Q1	us-gaap	Loss Contingency Patents Allegedly Infringed Number LossContingencyPatentsAllegedlyInfringedNumber	6	patent
CY2023Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	49540000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	46478000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	61825000	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	54526000	usd
CY2022Q4	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	67353000	usd
CY2022Q3	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	62808000	usd
CY2022Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	64224000	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	58014000	usd
CY2023Q4	us-gaap	Gross Profit GrossProfit	-12678000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	6457000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	26083000	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	21632000	usd
CY2022Q4	us-gaap	Gross Profit GrossProfit	38749000	usd
CY2022Q3	us-gaap	Gross Profit GrossProfit	34248000	usd
CY2022Q2	us-gaap	Gross Profit GrossProfit	35044000	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	31788000	usd
CY2023Q4	us-gaap	Net Income Loss NetIncomeLoss	-57233000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-44274000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-33278000	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-28048000	usd
CY2022Q4	us-gaap	Net Income Loss NetIncomeLoss	-7788000	usd
CY2022Q3	us-gaap	Net Income Loss NetIncomeLoss	-12134000	usd
CY2022Q2	us-gaap	Net Income Loss NetIncomeLoss	-47276000	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-15142000	usd
CY2023Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.87
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.22
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.68
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.42
CY2022Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.40
CY2022Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.62
CY2022Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-2.53
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.84
CY2023Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.87
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.22
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.68
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.42
CY2022Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.40
CY2022Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.62
CY2022Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-2.53
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.84
CY2023Q4	us-gaap	Assets Current AssetsCurrent	269185000	usd
CY2023Q3	us-gaap	Assets Current AssetsCurrent	311307000	usd
CY2023Q2	us-gaap	Assets Current AssetsCurrent	365944000	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	416045000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	451240000	usd
CY2022Q3	us-gaap	Assets Current AssetsCurrent	366312000	usd
CY2022Q2	us-gaap	Assets Current AssetsCurrent	373313000	usd
CY2022Q1	us-gaap	Assets Current AssetsCurrent	236784000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	77106000	usd
CY2023Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	95326000	usd
CY2023Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	93080000	usd
CY2023Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	80534000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	69748000	usd
CY2022Q3	us-gaap	Assets Noncurrent AssetsNoncurrent	61845000	usd
CY2022Q2	us-gaap	Assets Noncurrent AssetsNoncurrent	50779000	usd
CY2022Q1	us-gaap	Assets Noncurrent AssetsNoncurrent	29907000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	87747000	usd
CY2023Q3	us-gaap	Liabilities Current LiabilitiesCurrent	92406000	usd
CY2023Q2	us-gaap	Liabilities Current LiabilitiesCurrent	102923000	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	108607000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	105839000	usd
CY2022Q3	us-gaap	Liabilities Current LiabilitiesCurrent	98258000	usd
CY2022Q2	us-gaap	Liabilities Current LiabilitiesCurrent	85716000	usd
CY2022Q1	us-gaap	Liabilities Current LiabilitiesCurrent	74037000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	430374000	usd
CY2023Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	430312000	usd
CY2023Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	429902000	usd
CY2023Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	430017000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	430330000	usd
CY2022Q3	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	314405000	usd
CY2022Q2	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	314502000	usd
CY2022Q1	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	149494000	usd
CY2021	ecd	Peo Actually Paid Comp Amt PeoActuallyPaidCompAmt	6422427	usd
CY2021	ecd	Non Peo Neo Avg Total Comp Amt NonPeoNeoAvgTotalCompAmt	2356048	usd
CY2021	ecd	Non Peo Neo Avg Comp Actually Paid Amt NonPeoNeoAvgCompActuallyPaidAmt	2997001	usd
CY2021	ecd	Total Shareholder Rtn Amt TotalShareholderRtnAmt	115.4	usd
CY2021	ecd	Peer Group Total Shareholder Rtn Amt PeerGroupTotalShareholderRtnAmt	125.4	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	2100000	usd
CY2021	ecd	Co Selected Measure Amt CoSelectedMeasureAmt	231300000	usd
CY2023	ecd	Peo Name PeoName	Taylor Harris
CY2023	ecd	Peo Total Comp Amt PeoTotalCompAmt	7279813	usd
CY2023	ecd	Peo Actually Paid Comp Amt PeoActuallyPaidCompAmt	2111276	usd
CY2023	ecd	Non Peo Neo Avg Total Comp Amt NonPeoNeoAvgTotalCompAmt	663439	usd
CY2023	ecd	Non Peo Neo Avg Comp Actually Paid Amt NonPeoNeoAvgCompActuallyPaidAmt	-312230	usd
CY2023	ecd	Total Shareholder Rtn Amt TotalShareholderRtnAmt	9.9	usd
CY2023	ecd	Peer Group Total Shareholder Rtn Amt PeerGroupTotalShareholderRtnAmt	106.3	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	-162800000	usd
CY2023	ecd	Co Selected Measure Amt CoSelectedMeasureAmt	212400000	usd
CY2022	ecd	Peo Total Comp Amt PeoTotalCompAmt	2597552	usd
CY2022	ecd	Peo Actually Paid Comp Amt PeoActuallyPaidCompAmt	2761857	usd
CY2022	ecd	Non Peo Neo Avg Total Comp Amt NonPeoNeoAvgTotalCompAmt	966115	usd
CY2022	ecd	Non Peo Neo Avg Comp Actually Paid Amt NonPeoNeoAvgCompActuallyPaidAmt	673736	usd
CY2022	ecd	Total Shareholder Rtn Amt TotalShareholderRtnAmt	123.5	usd
CY2022	ecd	Peer Group Total Shareholder Rtn Amt PeerGroupTotalShareholderRtnAmt	99.8	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	-82300000	usd
CY2022	ecd	Co Selected Measure Amt CoSelectedMeasureAmt	252400000	usd
CY2021	ecd	Peo Total Comp Amt PeoTotalCompAmt	4065626	usd
CY2020	ecd	Peo Total Comp Amt PeoTotalCompAmt	1334582	usd
CY2020	ecd	Peo Actually Paid Comp Amt PeoActuallyPaidCompAmt	-350182	usd
CY2020	ecd	Non Peo Neo Avg Total Comp Amt NonPeoNeoAvgTotalCompAmt	1062163	usd
CY2020	ecd	Non Peo Neo Avg Comp Actually Paid Amt NonPeoNeoAvgCompActuallyPaidAmt	853506	usd
CY2020	ecd	Total Shareholder Rtn Amt TotalShareholderRtnAmt	67.3	usd
CY2020	ecd	Peer Group Total Shareholder Rtn Amt PeerGroupTotalShareholderRtnAmt	130.0	usd
CY2020	us-gaap	Net Income Loss NetIncomeLoss	-23900000	usd
CY2020	ecd	Co Selected Measure Amt CoSelectedMeasureAmt	147700000	usd
CY2023	ecd	Co Selected Measure Name CoSelectedMeasureName	revenue
CY2023	ecd	Peo Total Comp Amt PeoTotalCompAmt	7279813	usd
CY2023	ecd	Peo Actually Paid Comp Amt PeoActuallyPaidCompAmt	2111276	usd
CY2023	ecd	Non Peo Neo Avg Total Comp Amt NonPeoNeoAvgTotalCompAmt	663439	usd
CY2023	ecd	Non Peo Neo Avg Comp Actually Paid Amt NonPeoNeoAvgCompActuallyPaidAmt	-312230	usd
CY2022	ecd	Peo Total Comp Amt PeoTotalCompAmt	2597552	usd
CY2022	ecd	Peo Actually Paid Comp Amt PeoActuallyPaidCompAmt	2761857	usd
CY2022	ecd	Non Peo Neo Avg Total Comp Amt NonPeoNeoAvgTotalCompAmt	966115	usd
CY2022	ecd	Non Peo Neo Avg Comp Actually Paid Amt NonPeoNeoAvgCompActuallyPaidAmt	673736	usd
CY2021	ecd	Peo Total Comp Amt PeoTotalCompAmt	4065626	usd
CY2021	ecd	Peo Actually Paid Comp Amt PeoActuallyPaidCompAmt	6422427	usd
CY2021	ecd	Non Peo Neo Avg Total Comp Amt NonPeoNeoAvgTotalCompAmt	2356048	usd
CY2021	ecd	Non Peo Neo Avg Comp Actually Paid Amt NonPeoNeoAvgCompActuallyPaidAmt	2997001	usd
CY2020	ecd	Peo Total Comp Amt PeoTotalCompAmt	1334582	usd
CY2020	ecd	Peo Actually Paid Comp Amt PeoActuallyPaidCompAmt	-350182	usd
CY2020	ecd	Non Peo Neo Avg Total Comp Amt NonPeoNeoAvgTotalCompAmt	1062163	usd
CY2020	ecd	Non Peo Neo Avg Comp Actually Paid Amt NonPeoNeoAvgCompActuallyPaidAmt	853506	usd

Files In Submission

Name	View Source	Status
0001628280-24-022628-index-headers.html	Edgar Link	pending
0001628280-24-022628-index.html	Edgar Link	pending
0001628280-24-022628.txt	Edgar Link	pending
0001628280-24-022628-xbrl.zip	Edgar Link	pending
a2023inducementplan.htm	Edgar Link	pending
clawbackpolicy10262023.htm	Edgar Link	pending
cutr-20231231.htm	Edgar Link	pending
cutr-20231231.xsd	Edgar Link	pending
cutr-20231231xex211listofs.htm	Edgar Link	pending
cutr-20231231xexx231.htm	Edgar Link	pending
cutr-20231231xexx313.htm	Edgar Link	pending
cutr-20231231xexx314.htm	Edgar Link	pending
cutr-20231231xexx321.htm	Edgar Link	pending
cutr-20231231_g1.jpg	Edgar Link	pending
cutr-20231231_g2.jpg	Edgar Link	pending
cutr-20231231_g3.jpg	Edgar Link	pending
cutr-20231231_g4.jpg	Edgar Link	pending
cutr-jabilsettlement.htm	Edgar Link	pending
cutr-jabilsettlement001.jpg	Edgar Link	pending
cutr-jabilsettlement002.jpg	Edgar Link	pending
cutr-jabilsettlement003.jpg	Edgar Link	pending
cutr-jabilsettlement004.jpg	Edgar Link	pending
cutr-jabilsettlement005.jpg	Edgar Link	pending
cutr-jabilsettlement006.jpg	Edgar Link	pending
cutr-jabilsettlement007.jpg	Edgar Link	pending
cutr-jabilsettlement008.jpg	Edgar Link	pending
cutr-jabilsettlement009.jpg	Edgar Link	pending
cutr-jabilsettlement010.jpg	Edgar Link	pending
cutr-jabilsettlement011.jpg	Edgar Link	pending
cutr-jabilsettlement012.jpg	Edgar Link	pending
cutr-jabilsettlement013.jpg	Edgar Link	pending
cutr-jabilsettlement014.jpg	Edgar Link	pending
cutr-jabilsettlement015.jpg	Edgar Link	pending
cutr-jabilsettlement016.jpg	Edgar Link	pending
cutr-jabilsettlement017.jpg	Edgar Link	pending
cutr-jabilsettlement018.jpg	Edgar Link	pending
cutr-jabilsettlement019.jpg	Edgar Link	pending
cutr-jabilsettlement020.jpg	Edgar Link	pending
cutr-jabilsettlement021.jpg	Edgar Link	pending
cutr-jabilsettlement022.jpg	Edgar Link	pending
cutr-jabilsettlement023.jpg	Edgar Link	pending
cutr-jabilsettlement024.jpg	Edgar Link	pending
cutr-jabilsettlement025.jpg	Edgar Link	pending
cutr-jabilsettlement026.jpg	Edgar Link	pending
cutr-zosettlement.htm	Edgar Link	pending
cutr-20231231_def.xml	Edgar Link	unprocessable
cutr-20231231_lab.xml	Edgar Link	unprocessable
cutr-20231231_pre.xml	Edgar Link	unprocessable
cutr-20231231_htm.xml	Edgar Link	completed
cutr-zosettlement001.jpg	Edgar Link	pending
cutr-zosettlement002.jpg	Edgar Link	pending
cutr-zosettlement003.jpg	Edgar Link	pending
cutr-zosettlement004.jpg	Edgar Link	pending
cutr-zosettlement005.jpg	Edgar Link	pending
cutr-zosettlement006.jpg	Edgar Link	pending
cutr-zosettlement007.jpg	Edgar Link	pending
cutr-zosettlement008.jpg	Edgar Link	pending
cutr-zosettlement009.jpg	Edgar Link	pending
cutr-zosettlement010.jpg	Edgar Link	pending
cutr-zosettlement011.jpg	Edgar Link	pending
cutr-zosettlement012.jpg	Edgar Link	pending
cutr-zosettlement013.jpg	Edgar Link	pending
cutr-zosettlement014.jpg	Edgar Link	pending
cutr-zosettlement015.jpg	Edgar Link	pending
cutr-zosettlement016.jpg	Edgar Link	pending
cutr-zosettlement017.jpg	Edgar Link	pending
cutr-zosettlement018.jpg	Edgar Link	pending
cutr-zosettlement019.jpg	Edgar Link	pending
cutr-zosettlement020.jpg	Edgar Link	pending
cutr-zosettlement021.jpg	Edgar Link	pending
cutr-zosettlement022.jpg	Edgar Link	pending
cutr-zosettlement023.jpg	Edgar Link	pending
cutr-zosettlement024.jpg	Edgar Link	pending
cutr-zosettlement025.jpg	Edgar Link	pending
cutr-zosettlement026.jpg	Edgar Link	pending
cutr-zosettlement027.jpg	Edgar Link	pending
cutr-zosettlement028.jpg	Edgar Link	pending
cutr-zosettlement029.jpg	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_16.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
spofferletter.htm	Edgar Link	pending
spofferletter001.jpg	Edgar Link	pending
spofferletter002.jpg	Edgar Link	pending
spofferletter003.jpg	Edgar Link	pending
spofferletter004.jpg	Edgar Link	pending
spofferletter005.jpg	Edgar Link	pending
spofferletter006.jpg	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
cutr-20231231_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CUTR
CUTERA INC Stock $cutr

2023 Q4 Form 10-K Financial Statement

#000162828024022628 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CUTR CUTERA INC Stock $cutr

2023 Q4 Form 10-K Financial Statement

#000162828024022628 Filed on May 10, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CUTR
CUTERA INC Stock $cutr